A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis
Status:
Completed
Trial end date:
2009-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to better understand how fluocinonide cream 0.1%
(Vanos®) works when people use it to treat atopic dermatitis for just a few days.
Phase:
Phase 4
Details
Lead Sponsor:
Wake Forest University Health Sciences Wake Forest University Health Sciences need to be deleted